Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR

  • Eileen M. Dunne,

    Roles Formal analysis, Methodology, Writing – original draft

    Affiliations Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia

  • Molina Choummanivong,

    Roles Data curation, Investigation

    Affiliation University of Health Sciences, Vientiane, Lao People’s Democratic Republic

  • Eleanor F. G. Neal,

    Roles Data curation, Methodology, Writing – review & editing

    Affiliations Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia

  • Kathryn Stanhope,

    Roles Data curation, Investigation

    Affiliation Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

  • Cattram D. Nguyen,

    Roles Methodology

    Affiliations Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia

  • Anonh Xeuatvongsa,

    Roles Conceptualization, Resources

    Affiliation Ministry of Health, Vientiane, Lao People's Democratic Republic

  • Catherine Satzke,

    Roles Methodology, Supervision, Writing – review & editing

    Affiliations Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia, Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Australia

  • Vanphanom Sychareun,

    Roles Conceptualization, Methodology

    Affiliation University of Health Sciences, Vientiane, Lao People’s Democratic Republic

  • Fiona M. Russell

    Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

    fmruss@unimelb.edu.au

    Affiliations Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia

Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR

  • Eileen M. Dunne, 
  • Molina Choummanivong, 
  • Eleanor F. G. Neal, 
  • Kathryn Stanhope, 
  • Cattram D. Nguyen, 
  • Anonh Xeuatvongsa, 
  • Catherine Satzke, 
  • Vanphanom Sychareun, 
  • Fiona M. Russell
PLOS
x

Abstract

Nasopharyngeal carriage of Streptococcus pneumoniae (the pneumococcus) is a precursor to pneumococcal disease. Several host and environmental factors have been associated with pneumococcal carriage, however few studies have examined the relationship between host factors and pneumococcal carriage density. We sought to identify risk factors for pneumococcal carriage and density using data from cross-sectional pneumococcal carriage surveys conducted in the Lao People's Democratic Republic before and after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13). Nasopharyngeal swabs were collected infants from aged 5–8 weeks old (n = 999) and children aged 12–23 months (n = 1,010), pneumococci detected by quantitative PCR, and a risk factor questionnaire completed. Logistic and linear regression models were used to evaluate associations between participant characteristics and pneumococcal carriage and density. In infants aged 5–8 weeks, living in a household with two or more children under the age of five years (aOR 1.97; 95% CI 1.39–2.79) and low family income (aOR 1.64; 95% CI 0.99–2.72) were positively associated with pneumococcal carriage. For children aged 12–23 months, upper respiratory tract infection (URTI) symptoms (aOR 2.64; 95% CI 1.97–3.53), two or more children under five in the household (aOR 2.40; 95% CI 1.80–3.20), and rural residence (aOR 1.84, 95% CI 1.35–2.50) were positively associated with pneumococcal carriage. PCV13 vaccination was negatively associated with carriage of PCV13 serotypes (aOR 0.60; 95% CI 0.44–0.83). URTI symptoms (p < 0.001), current breastfeeding (p = 0.005), rural residence (p = 0.012), and delivery by Caesarean section (p = 0.035) were associated with higher mean pneumococcal density in pneumococcal carriers (both age groups combined). This study provides new data on pneumococcal carriage and density in a high disease burden setting in southeast Asia.

Introduction

The bacterium Streptococcus pneumoniae (the pneumococcus) is a significant global pathogen, and in 2015 was responsible for an estimated 317,300 deaths, most due to pneumonia, in children under five years old.[1] The majority of pneumococcal disease burden occurs in low- and middle- income countries (LMICs), believed to be due to poor access to health care and pneumococcal vaccines, and higher rates of risk factors such as HIV infection and malnutrition.[2] Other risk factors such as overcrowding contribute to the higher burden of pneumococcal disease in LMICs.[3]

Pneumococci are commonly carried in the nasopharynx of young children, with reported prevalence rates in LMICs ranging from 6 to 93%.[3] Although pneumococcal carriage is typically asymptomatic, it is a precursor for the development of pneumococcal disease and serves as the reservoir for this exclusively human pathogen.[4] High pneumococcal density (bacterial load) in the nasopharynx is associated with lower respiratory tract infections and pediatric pneumonia.[5]. In mouse models, high pneumococcal density in the nasopharynx increases transmission.[6]

Several host, socio-economic, and environmental factors are risk factors for pneumococcal carriage. These include day care attendance, living in a household with other young children, low socio-economic status, and symptoms of an upper respiratory tract infection (URTI).[711] In some studies, children in rural areas had higher odds of pneumococcal carriage compared to those living in urban settings.[12, 13] Co-infection with respiratory viruses, URTI symptoms, and low family income have been linked to higher pneumococcal density in children.[5, 9, 14, 15]

The Lao People’s Democratic Republic (Lao PDR) is a lower-middle income country in East Asia. Lao PDR has a mortality rate of 67 per 1000 children under five, and a high burden of pneumonia in children. (https://www.gavi.org/country/lao-pdr/ [Accessed 13 June 2019]). The 13-valent pneumococcal conjugate vaccine (PCV13), which provides protection against 13 pneumococcal serotypes, was introduced into the national infant immunization schedule in Lao PDR in late 2013. Previously, we conducted nasopharyngeal carriage surveys before and two years after PCV13 introduction to evaluate the impact of the PCV program on pneumococcal carriage in two age groups: young children aged 12–23 months (the majority of whom were PCV-vaccinated in the post-PCV13 survey), and unvaccinated infants aged 5–8 weeks.[16] Following PCV13 introduction, the carriage prevalence of overall pneumococci did not change. Prevalence of PCV13-serotypes declined significantly in 12–23 month old children (from 33% to 20%; adjusted prevalence ratio 0.77 [95% CI 0.61–0.96], and there was some evidence of indirect effects in 5–8 week old infants (decline from 7% to 5%, adjusted prevalence ratio 0.74 [95% CI 0.43–1.27). Here, we describe a secondary analysis conducted using data from these cross-sectional surveys to identify demographic and household factors associated with carriage of pneumococci overall, PCV13 serotype carriage, and pneumococcal carriage density.

Materials and methods

Study design and participants

Cross-sectional nasopharyngeal carriage surveys were conducted from November 2013—February 2014 (“pre-PCV”), and November 2015—February 2016 (“post-PCV”) as described previously.[16] Participants were enrolled in Vientiane, the capital of Lao PDR, and the rural Bolikhamxay Province. Urban participants were enrolled from maternal and child health centers during routine clinic visits. Rural participants were enrolled during maternal and child health visits and visits to surrounding households. Inclusion criteria were age (5–8 week old infants and 12–23 month old children), temperature ≤ 37°C per axilla, and having lived in the area for at least three consecutive months. Previous receipt of PCV13 was an exclusion criteria for children and infants during the first survey, for infants aged 5–8 weeks for the second survey. Nasopharyngeal swabs were collected and stored according to WHO guidelines.[17] Study staff completed a questionnaire to collect data on demographics and potential risk factors (chosen based upon the literature) for each participant. These data included: sex, ethnicity (self-reported), urban or rural residence, the presence of URTI symptoms (including coryza, allergic rhinitis, or cough), antibiotic usage in the previous two weeks, exposure to household cigarette smoke, main source of cooking fuel (wood, charcoal, gas, electricity, kerosene), number and ages of other children in the household, family income (Kip/week), mode of delivery, and current breastfeeding status. A binary value for poverty was created using the $1.25 USD per day value international poverty line recommended by the World Bank from 2008–2015 (http://www.worldbank.org/). PCV13 immunization history was obtained from participant vaccination status cards or health center records.

The study was undertaken according to the protocol approved by the Lao PDR Ministry of Health National Ethics Committee for Health Research (061-NECHR), the Western Pacific Regional Office Ethics Review Committee, and The Royal Children’s Hospital/Murdoch Children’s Research Institute Human Research Ethics Committee (HREC 33177A/HREC 33177B). Written informed consent was obtained from the parent or guardian for all participants.

Laboratory procedures

Samples were stored in ultra-low temperature freezers at the Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (LOMWRU, Vientiane, Lao PDR) until shipment on dry ice to the Murdoch Children’s Research Institute (Parkville, Australia) for microbiological analysis. Detection and quantification of pneumococci and pneumococcal serotyping were performed as previously described.[16] In brief, DNA extraction of 100 μl swab media was conducted using a MagNA Pure LC instrument (Roche) and pneumococci were detected and quantified by real-time quantitative PCR (qPCR) targeting the lytA gene.[18] A standard curve prepared using genomic DNA extracted from a reference isolate of S. pneumoniae (ATCC 6305) was used for quantification. The standard curve also served as a positive control, and extraction controls and no template controls were included as negative controls in each qPCR run.

Pneumococcal density data were reported in genome equivalents/ml (GE/ml). This unit approximates pneumococcal density with the assumption that each pneumococcal cell contains one genome (with a genome size of 2 Mb) and each genome contains one copy of the lytA gene, and an extraction volume of 0.1 ml swab media.

Pneumococcal-positive samples underwent molecular serotyping by microarray following a culture-amplification step on horse blood agar plates containing 5 μg/ml of gentamicin (Oxoid). DNA was extracted using a QIAcube HT instrument (Qiagen) and microarray performed using the Senti-SPv1.5 microarray (BUGS Bioscience).[19]

Statistical analysis

Data entry and cleaning were conducted using EpiData version 3.1 and Stata version 15.1 as previously described.[16] Statistical analyses was performed using Stata 15.0. To evaluate the relationship between participant characteristics and pneumococcal carriage, unadjusted and adjusted odds ratios and 95% confidence intervals (CIs) were determined using logistic regression. Potential risk factors were examined separately for each age group for overall pneumococcal carriage. The following variables (shown in Table 1) were evaluated in the univariable analysis: sex, location (urban or rural), ethnicity, the presence of upper URTI symptoms, antibiotic use in the previous two weeks, exposure to cigarette smoke, primary source of fuel, two or more children under the age of five years in the household, family income below the poverty line, mode of delivery, breastfeeding status, and survey year. Primary source of fuel was categorized into biofuels (wood and charcoal) or non-biofuels (electricity, gas, and kerosene) and ethnicity data were reclassified as Lao Loum or other prior to analysis. For 12–23 month old children, PCV13 vaccination status was also assessed, however survey year was omitted due to co-linearity with PCV13 status. Adjusted odds ratios and 95% CI were calculated using multivariable logistic regression models included variables selected a priori based on the literature (URTI symptoms, two or more children under the age of five years in the household, poverty) and any variables with p < 0.2 by univariable analysis. Similar analyses were also undertaken for PCV13 serotype carriage for the 12–23 month old age group. When serotyping results were not available from a sample due to technical issues, that sample was excluded from serotype-specific analyses.

thumbnail
Table 1. Characteristics of pneumococcal carriage survey participants in Lao PDR, conducted before and two years after PCV13 introduction.

https://doi.org/10.1371/journal.pone.0224392.t001

Pneumococcal density data were log10 transformed prior to analysis. Potential relationships between potential risk factors described above and pneumococcal density we evaluated using linear regression. This analysis combined both age groups and was restricted to pneumococcal carriers. Multivariable linear regression models included URTI symptoms (selected a priori) plus variables with p < 0.2 by univariable analysis. Results were reported as the unadjusted and adjusted coefficients (the difference in mean density) with 95% CIs and p values.

Results

Table 1 summarizes characteristics of the 2,009 study participants. Generally, participant characteristics were similar between age groups with a few exceptions: very few of the 5–8 week old infants lived in rural areas, URTI symptoms and recent antibiotic use was much more common in 12–23 month old children, and breastfeeding was more common in the young infants. In the post-PCV survey, 448/497 (90.1%) of participants aged 12–23 months had received two or more doses of PCV13. Information on PCV13 immunization history was not available for ten participants.

One swab was excluded due to technical issues, and 9 swabs that were positive for pneumococcus were not able to be serotyped. For 5–8 week old infants, 157/999 (15.7%; 95% CI 13.5–18.1) carried pneumococcus, and 58/995 (5.8%; 95% CI 4.5–7.5) carried a PCV13 serotype. For the 12–23 month old children, 511/1009 (50.6%; 95% CI 47.5–53.8) carried pneumococcus, and 265/1005 (26.4%; 95% CI 23.7–29.2) carried a PCV13 serotype. Pneumococcal density was variable among carriers, ranging from 2.9 to 8.2 log10 GE/ml. The median carriage density was 5.8 log10 GE/ml (range 3.5–8.2; IQR 5.1–6.6) in 5–8 week old infants and 5.8 log10 GE/ml (range 2.9–8.1; IQR 5.0–6.5) in 12–23 month old children.

Associations between participant characteristics and overall pneumococcal carriage for each age group are shown in Tables 2 and 3. For 5–8 week old infants, living in a household with two or more children under the age of five years (aOR 1.97; 95% CI 1.39–2.79) was positively associated with pneumococcal carriage, and there was some evidence for a positive association with having a family income below the poverty line (aOR 1.64; 95% CI 0.99–2.71). Living in a household with two or more children under five was positively associated with pneumococcal carriage in children aged 12–23 months (aOR 2.40; 95% CI 1.80–3.20), along with rural residence (aOR 1.84; 95% CI 1.35–2.50) and having URTI symptoms (aOR 2.64; 95% CI 1.97–3.53). URTI symptoms were significantly more common in rural children (336/470, 71.5%) compared to children from urban areas (289/540, 53.7%, p < 0.001, chi-squared test).

thumbnail
Table 2. Univariable and multivariable analysis of participant characteristics associated with pneumococcal carriage in infants aged 5–8 weeks (n = 999).

https://doi.org/10.1371/journal.pone.0224392.t002

thumbnail
Table 3. Univariable and multivariable analysis of participant characteristics associated with pneumococcal carriage in children aged 12–23 months (n = 1,009).

https://doi.org/10.1371/journal.pone.0224392.t003

Carriage of PCV13 serotypes was also examined, as these serotypes are more likely to cause invasive pneumococcal disease, and specifically targeted by the PCV immunization program. Due to the relatively small number of 5–8 week old infants who carried a PCV13 serotype, this analysis was only conducted for 12–23 month old children (Table 4). Factors identified to be positively associated with PCV13 serotype carriage were consistent with those associated with overall pneumococcal carriage (rural residence, presence of URTI symptoms, and living in a household with two or more children under five). Additionally, previous PCV13 vaccination was associated with reduced odds of PCV13 serotype carriage (aOR 0.60; 95% CI 0.44–0.83). To examine factors associated with PCV13 serotype carriage prior to PCV13 introduction, we conducted an analysis only including children from the pre-PCV survey. Results were consistent with those from the analysis of both surveys presented in Table 4: following multivariable analysis, rural living (aOR 1.70; 95% CI 1.08–2.68; p = 0.021), the presence of URTI symptoms (aOR 2.44; 95%CI 1.46–4.07, p = 0.001), and living in a household with two or more children under five (aOR 2.59; 95%CI 1.72–3.89; p < 0.001) were associated with PCV13 serotype carriage in the pre-PCV13 survey.

thumbnail
Table 4. Univariable and multivariable analysis of participant characteristics associated with carriage of PCV13 serotypes in children aged 12–23 months (n = 1,005).

https://doi.org/10.1371/journal.pone.0224392.t004

Next, we examined factors associated with pneumococcal carriage density in children and infants positive for pneumococcal carriage. As no differences in pneumococcal density were observed between the two age groups surveyed (p = 0.574, t-test), data were pooled for analysis by linear regression, with results shown in Table 5. Having URTI symptoms was associated with increased pneumococcal density, with an adjusted coefficient (difference between means) of 0.34 log10 GE/ml (95% CI 0.17–0.50; p < 0.001). Rural residence (0.20 log10 GE/ml; 95% CI 0.05–0.36; p = 0.012), delivery via Caesarean section (0.22 log10 GE/ml; 95% CI 0.02–0.43; p = 0.035) and current breastfeeding (0.24 log10 GE/ml; 95% CI 0.07–0.41; p = 0.005) were also associated with higher pneumococcal density. As reported previously, pneumococcal densities were higher in the post-PCV13 survey compared with the pre-PCV13 survey (0.64 log10 GE/ml; 95% CI 0.42–0.87; p < 0.001).[16]

thumbnail
Table 5. Univariable and multivariable analysis of factors associated with pneumococcal density in infants and young children positive for pneumococcal carriage (n = 668).

https://doi.org/10.1371/journal.pone.0224392.t005

Discussion

Southeast Asia has one of the highest estimated incidence of pneumococcal disease in children in the world.[1] However, relatively few studies have examined risk factors for pneumococcal carriage, a precursor to pneumococcal disease, in this setting. We examined carriage in infants aged 5–8 weeks old prior to their first dose of PCV13, as unvaccinated neonates and young infants are particularly vulnerable to invasive bacterial infections, including those caused by pneumococcus.[20] In this age group, having and two or more children under five in the household and low family income were risk factors for pneumococcal carriage. In Lao PDR children aged 12–23 months, URTI symptoms, two or more children under five years old in the household, and rural residence were associated with pneumococcal carriage. Results from our study were similar with other pneumococcal carriage studies conducted in the region. In Vietnam, age and day care attendance were associated with pneumococcal carriage in children under five.[21] In a longitudinal study of infants in Thailand followed from birth, maternal smoking and presence of other young children in the household were associated with earlier pneumococcal colonization.[22] Living in a household containing two or more children under five years old and URTI symptoms were identified as risk factors for pneumococcal carriage in Indonesian children aged 12–24 months.[9] Results from our study advance upon previous work by assessing risk factors for pneumococcal carriage in a unique population within which PCV has been recently introduced.

Lao PDR is a diverse nation, with 49 distinct ethnic groups, and historically, ethnic minority groups have had poorer health status, including increased childhood mortality and lower vaccination rates.[23] As our study was conducted in the capital city and a nearby province, relatively few participants belonging to ethnic minorities were enrolled, and therefore results are not representative of the overall population of Lao PDR. Nearly half of 12–23 month old participants, compared with 7% of 5–8 week old infants, lived in rural areas; this may explain why rural residence was identified as a risk factor only in the older age group. Consistent with a previous study on respiratory infection burden in Lao PDR, children in rural areas were more likely to have UTRI symptoms.[24]

Risk factors for PCV13 carriage were similar to those associated with overall pneumococcal carriage, and as expected, children who received two or three doses of PCV13 had reduced odds of carrying a PCV13 serotype. In later years following PCV13 introduction, carriage of PCV13 serotypes may become associated with contact with under-vaccinated communities and/or interactions with older, unvaccinated children and adolescents.[25]

In our study, pneumococcal carriage was not associated with recent antibiotic use; this may be due to the unreliability of parent-reported data on antibiotic use, which has been previously documented in Lao PDR, and high rates of antimicrobial resistance in pneumococci.[26] We previously reported that over 70% of pneumococcal-positive carriage samples harbored at least one antimicrobial resistance gene.[16] Results from studies examining cigarette exposure as a risk factor for pneumococcal carriage have reported varying results, and we did not find an association in our study population.[9, 2729] However, exposure to cigarette smoke can be difficult to determine without monitoring, and levels of smoke exposure and maternal smoking were not assessed in our study. Indoor air pollution caused by the use of solid fuels such as wood and charcoal as cooking fuel is a risk factor for pneumonia in children.[30] In our study, biofuels were associated with increased pneumococcal carriage in 12–23 month old children by univariable analysis but not following multivariable analysis.

High pneumococcal density in the nasopharynx is associated with respiratory infections including pneumonia in children.[5, 31, 32] Additionally, pneumococcal density in the nasopharynx has been investigated as a potential diagnostic tool for pediatric pneumonia.[31] As such, it is important to understand what underlying host factors may influence pneumococcal carriage density, and our study provides new data on this topic. Consistent with other studies, individual pneumococcal carriage density varied widely.[33,34] We identified several factors associated with increased pneumococcal density. The presence of URTI symptoms was positively associated with pneumococcal density in our study, consistent with results from community carriage surveys in young children in Indonesia and Belgium.[9, 35] Living in a rural area was associated with increased pneumococcal density; this may be related to socio-economic and environmental differences between urban and rural households. Pneumococcal density was higher in the post-PCV carriage survey, but as this was the case for both PCV13 serotypes and non-PCV13 serotypes, this was not attributed to PCV.[16] We have performed pneumococcal density studies before and after PCV in Fiji, Mongolia, and Lao PDR. Similar to our findings in Lao PDR, density of both PCV13 and non-PCV13 serotypes was higher in children following PCV13 introduction in Mongolia.[36] In contrast, density of both vaccine serotypes and non-vaccine serotypes declined in children in Fiji following the introduction of PCV10.[34] In an experimental human pneumococcal challenge model, adults who received PCV13 had lower pneumococcal density compared with those who received a control vaccine.[37] To date, there is not consistent evidence of an effect of PCV on pneumococcal density in children. Variations in density observed in cross-sectional studies with carriage assessed during different years may be temporal and/or related to as number of unmeasured factors.

Two previously unreported factors were linked with higher pneumococcal density: delivery by Caesarean section and current breastfeeding. Unlike URTI symptoms and rural living, both of these factors were not associated with the likelihood of pneumococcal carriage, but rather with increased pneumococcal loads in pneumococcal carriers. Mode of delivery has been found to significantly affect the development of the nasopharyngeal microbiome through the first six months of life.[38] Caesarean birth was associated with a high abundance of Streptococcus from early life in a nasopharyngeal microbiome study of Dutch infants.[39] It is possible that Caesarean delivery may influence microbiome development in a manner that supports pneumococcal growth, however this finding requires further investigation. We did not collect detailed breastfeeding data on exclusive vs. non-exclusive breastfeeding, formula use, and duration of exclusive breastfeeding, so the relationship between breastfeeding and increased pneumococcal density should be interpreted with caution. A study comparing the nasopharyngeal microbiome of exclusively breast-fed infants with formula-fed infants found differences in bacterial community composition at six weeks of age that resolved by six months.[40] The generation R study examining risk factors for pneumococcal carriage in Dutch infants found no association between pneumococcal carriage and duration of breast-feeding or exclusive breast-feeding at 1.5, 6 or 14 months of age.[11] Only 20% of participants in the older age group reported current breastfeeding, and it is possible that there may be underlying socioeconomic and other differences between the breastfeeding group and those in the same age group who were no longer breastfed that were not captured therefore not included in the adjusted analysis. Alternatively, it is possible that breastfeeding may negatively affect bacterial species such as Staphylococcus aureus that are competitors of pneumococcus, therefore facilitating pneumococcal growth, although this is speculative.[41]

Viral testing was not conducted in our study as we recruited generally healthy, afebrile children from the community. However, > 60% of participants aged 12–23 months had URTI symptoms. Several studies have identified positive associations between respiratory viruses and pneumococcal carriage and density in the nasopharynx. In children attending day-care in Portugal, pneumococcal density was significantly higher in children who tested positive for a respiratory virus.[14] In a UK clinical trial, children who received the live attenuated influenza vaccine had significantly higher pneumococcal density compared with controls when assessed 28 days after vaccination.[42] In rural children in Peru, respiratory virus detection was positively associated with pneumococcal density.[43] A surveillance study on influenza-like illness in households in Vientiane, Lao PDR found that pneumococcus, influenza virus, and parainfluenza virus were the most common pathogens detected in children aged 0–4 years, and that co-detection of pneumococcus and respiratory viruses was common.[44] Combined, these findings suggest that children in our study with high pneumococcal density and URTI symptoms might have been co-infected with a respiratory virus. However, asymptomatic viral co-infection may also influence pneumococcal density: a study in American children found that pneumococcal densities were higher when a respiratory virus was detected, even in the absence of URTI symptoms.[15]

We did not evaluate HIV infection status or malnutrition, factors that may influence pneumococcal carriage, in our study. Lao PDR has a low prevalence of HIV (estimated at 0.2% of 18 to 49 year olds in 2013) and therefore we assume similar low prevalence in our participants.[45] Childhood malnutrition is a major public health issue in Lao PDR. In 2015, the prevalence of stunting, which is an indicator of chronic malnutrition, in children under five was 36%.[23] Malnutrition was likely common among the study population, and has been identified as a risk factor for pneumococcal carriage in other studies.[46, 47]

In summary, we have identified host and socio-economic risk factors for pneumococcal carriage and density in infants and young children in Lao PDR. Our findings highlight links between URTI infections, pneumococcal carriage, and pneumococcal density, and also identify children living in rural areas as having increased risk of pneumococcal carriage.

Acknowledgments

We thank study participants and their families, and the University of Health Sciences project staff for enrolment and sample collection. We thank the Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit for sample processing, and the pneumococcal microbiology lab at the Murdoch Children’s Research Institute and the Bacterial Microarray Group at St George's, University of London for microbiological analysis.

References

  1. 1. Wahl B, O'Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–2015. Lancet Glob Health. 2018;6(7):e744–e57. pmid:29903376
  2. 2. Mehr S, Wood N. Streptococcus pneumoniae—a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev. 2012;13(4):258–64. pmid:23069126
  3. 3. Adegbola RA, DeAntonio R, Hill PC, Roca A, Usuf E, Hoet B, et al. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One. 2014;9(8):e103293. pmid:25084351
  4. 4. Bogaert D, de Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144–54. pmid:14998500
  5. 5. Vu HTT, Yoshida LM, Suzuki M, Nguyen HAT, Nguyen CDL, Nguyen ATT, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. 2011;30(1):11–8 pmid:20686433
  6. 6. Short KR, Reading PC, Wang N, Diavatopoulos DA, Wijburg OL. Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. MBio. 2012;3(5).
  7. 7. Koliou MG, Andreou K, Lamnisos D, Lavranos G, Iakovides P, Economou C, et al. Risk factors for carriage of Streptococcus pneumoniae in children. BMC Pediatrics. 2018;18(1):144. pmid:29699525
  8. 8. Adetifa IMO, Adamu AL, Karani A, Waithaka M, Odeyemi KA, Okoromah CAN, et al. Nasopharyngeal pneumococcal carriage in Nigeria: a two-site, population-based survey. Sci Rep. 2018;8(1):3509. pmid:29472635
  9. 9. Fadlyana E, Dunne EM, Rusmil K, Tarigan R, Sudigdoadi S, Murad C, et al. Risk factors associated with nasopharyngeal carriage and density of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in young children living in Indonesia. Pneumonia. 2018;10(1):14. pmid:30603377
  10. 10. Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JAG. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi District, Kenya. Pediatr Infect Dis J. 2008;27. pmid:18162940
  11. 11. Labout JAM, Duijts L, Arends LR, Jaddoe VWV, Hofman A, de Groot R, et al. Factors associated with pneumococcal carriage in healthy Dutch Infants: The Generation R Study. J Pediatr. 2008;153(6):771–6.e1. pmid:18621390
  12. 12. Principi N, Marchisio P, Schito GC, Mannelli S. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Pediatric Infect Dis J. 1999;18(6):517–23.
  13. 13. Hanieh S, Hamaluba M, Kelly DF, Metz JA, Wyres KL, Fisher R, et al. Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation. PLoS One. 2014;9(6):e98739. pmid:24905574
  14. 14. Rodrigues F, Foster D, Nicoli E, Trotter C, Vipond B, Muir P, et al. Relationships between rhinitis symptoms, respiratory viral infections and nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in children attending daycare. Pediatric Infect Dis J. 2013;32(3):227–32. pmid:23558321
  15. 15. DeMuri GP, Gern JE, Eickhoff JC, Lynch SV, Wald ER. Dynamics of bacterial colonization with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection. Clin Infect Dis. 2018;66(7):1045–53. pmid:29121208
  16. 16. Satzke C, Dunne EM, Choummanivong M, Ortika BD, Neal EFG, Pell CL, et al. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019;37(2):296–305. pmid:30502068
  17. 17. Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013;32(1):165–79. pmid:24331112
  18. 18. Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45(8):2460–6. pmid:17537936
  19. 19. Satzke C, Dunne EM, Porter BD, Klugman KP, Mulholland EK. The PneuCarriage Project: a multi-centre comparative study to identify the best serotyping methods for examining pneumococcal carriage in vaccine evaluation studies. PLoS Med. 2015;12(11):e1001903; discussion e. pmid:26575033
  20. 20. Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, et al. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics. 2013;132(1):e17–e24. pmid:23733800
  21. 21. Nguyen HAT, Fujii H, Vu HTT, Parry CM, Dang AD, Ariyoshi K, et al. An alarmingly high nasal carriage rate of Streptococcus pneumoniae serotype 19F non-susceptible to multiple beta-lactam antimicrobials among Vietnamese children. BMC Infect Dis. 2019;19(1):241. pmid:30866853
  22. 22. Turner P, Turner C, Jankhot A, Helen N, Lee SJ, Day NP, et al. A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border. PLoS One. 2012;7(5):e38271. pmid:22693610
  23. 23. Overview of Lao health system development 2009–2017. Manila, Philippines. World Health Organization Regional Office for the Western Pacific. 2018. Licence: CC BY-NC-SA 3.0 IGO.
  24. 24. Mayxay M, Hansana V, Sengphilom B, Oulay L, Thammavongsa V, Somphet V, et al. Respiratory illness healthcare-seeking behavior assessment in the Lao People’s Democratic Republic (Laos). BMC Public Health. 2013;13(1):444. pmid:23642240
  25. 25. Weinberger DM, Pitzer VE, Regev-Yochay G, Givon-Lavi N, Dagan R. Association between the decline in pneumococcal disease in unimmunized adults and vaccine-derived protection against colonization in toddlers and preschool-aged children. Am J Epidemiol. 2018;188(1):160–8. pmid:30462150
  26. 26. Khennavong M, Davone V, Vongsouvath M, Phetsouvanh R, Silisouk J, Rattana O, et al. Urine antibiotic activity in patients presenting to hospitals in Laos: implications for worsening antibiotic resistance. Am J Trop Med Hyg. 2011;85(2):295–302. pmid:21813851
  27. 27. Greenberg D, Givon-Lavi N, Broides A, Blancovich I, Peled N, Dagan R. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis. 2006;42(7):897–903. pmid:16511750
  28. 28. Hadinegoro SR, Prayitno A, Khoeri MM, Djelantik IG, Dewi NE, Indriyani SA, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children under five years old in Central Lombok Regency, Indonesia. Southeast Asian J Trop Med Public Health. 2016;47(3):485–93. pmid:27405132
  29. 29. Farida H, Severin JA, Gasem MH, Keuter M, Wahyono H, van den Broek P, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in pneumonia-prone age groups in Semarang, Java Island, Indonesia. PLoS One. 2014;9(1):e87431. pmid:24498104
  30. 30. Dherani M, Pope D, Mascarenhas M, Smith KR, Weber M, Bruce N. Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis. Bull World Health Organ. 2008;86(5):390–8C. pmid:18545742
  31. 31. Baggett HC, Watson NL, Deloria Knoll M, Brooks WA, Feikin DR, Hammitt LL, et al. Density of upper respiratory colonization with Streptococcus pneumoniae and its role in the diagnosis of pneumococcal pneumonia among children aged <5 years in the PERCH study. Clin Infect Dis. 2017;64(suppl_3):S317–S27. pmid:28575365
  32. 32. Chochua S, D'Acremont V, Hanke C, Alfa D, Shak J, Kilowoko M, et al. Increased nasopharyngeal density and concurrent carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis are associated with pneumonia in febrile children. PLoS One. 2016;11(12):e0167725. pmid:27907156
  33. 33. Morpeth SC, Munywoki P, Hammitt LL, Bett A, Bottomley C, Onyango CO, et al. Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children. Sci Rep. 2018 Jul 23;8(1):11030. pmid:30038420
  34. 34. Effects of 10-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys. Dunne EM, Satzke C, Ratu FT, Neal EFG, Boelsen LK, Matanitobua S, et al. Lancet Glob Health. 2018 Dec;6(12):e1375–e1385. pmid:30420033
  35. 35. Wouters I, Van Heirstraeten L, Desmet S, Blaizot S, Verhaegen J, Goossens H, et al. Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme. Vaccine. 2018;36(1):15–22. pmid:29180027
  36. 36. von Mollendorf C, Dunne EM, La Vincente S, Ulziibayar M, Suuri B, Luvsantseren D, et al. Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019 Jul 9;37(30):4068–4075. pmid:31174939
  37. 37. German EL, Solórzano C, Sunny S, Dunne F, Gritzfeld JF, Mitsi E, et al. Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density. Vaccine. 2019 Jul 9;37(30):3953–3956. pmid:31176540
  38. 38. Bosch AATM, Levin E, van Houten MA, Hasrat R, Kalkman G, Biesbroek G, et al. Development of upper respiratory tract microbiota in infancy is affected by mode of delivery. EBioMedicine. 2016;9:336–45. pmid:27333043
  39. 39. Bosch AATM, Piters WAAdS, Houten Mav, Chu MLJN, Biesbroek G, Kool J, et al. Maturation of the infant respiratory microbiota, environmental drivers, and health consequences. a prospective cohort study. Am J Resp Crit Car Med. 2017;196(12):1582–90. pmid:28665684
  40. 40. Biesbroek G, Bosch AATM, Wang X, Keijser BJF, Veenhoven RH, Sanders EAM, et al. The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am J Resp Crit Car Med. 2014;190(3):298–308. pmid:24921688.
  41. 41. Heikkilä MP, Saris PE. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol. 2003;95(3):471–8. pmid:12911694
  42. 42. Thors V, Christensen H, Morales-Aza B, Vipond I, Muir P, Finn A. The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 Year Olds. A randomized controlled trial. Am J Resp Crit Car Med. 2016;193(12):1401–9. pmid:26742001
  43. 43. Fan RR, Howard LM, Griffin MR, Edwards KM, Zhu Y, Williams JV, et al. Nasopharyngeal pneumococcal density and evolution of acute respiratory illnesses in young children, Peru, 2009–2011. Emerg Infect Dis. 2016;22(11):1996–9. pmid:27767919
  44. 44. Rudge JW, Inthalaphone N, Pavlicek R, Paboriboune P, Flaissier B, Monidarin C, et al. “Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR”: A prospective, community-based cohort study. PLoS One. 2019;14(4):e0214207. pmid:30951544
  45. 45. Lao PDR country progress report, Global AIDS Response Progress Country Report, 2016.
  46. 46. Birindwa AM, Emgård M, Nordén R, Samuelsson E, Geravandi S, Gonzales-Siles L, et al. High rate of antibiotic resistance among pneumococci carried by healthy children in the eastern part of the Democratic Republic of the Congo. BMC Pediatrics. 2018;18(1):361. pmid:30453916
  47. 47. Verhagen LM, Hermsen M, Rivera-Olivero IA, Sisco MC, de Jonge MI, Hermans PW, et al. Nasopharyngeal carriage of respiratory pathogens in Warao Amerindians: significant relationship with stunting. Trop Med Int Health. 2017;22(4):407–14. pmid:28072501